Bioprinting Tissues
Can tissues and organs be printed better in orbit, and how close is it to patients?
Chapter summary
tissues can be printed in orbit, and soft structures that would collapse under their own weight on Earth hold their shape; Redwire's BioFabrication Facility printed a human knee meniscus on the ISS in 2023 and cultured it for 14 days.
Key takeaways
- 1
Printing organs for transplant remains a research goal for the 2030s and beyond, held back by vascularisation, maturation and regulation rather than gravity alone.
- 2
Ground bioprinting with supportive gels also keeps improving.
- 3
Setcoin scores bioprinted tissue 47, long-dated.
Keep reading with Space access
This chapter (405 words) is part of Space & aerospace. Space access opens every chapter of all 11 Space reports, with the interactive models, Excel downloads, Ask and named Atlas records.
- Global Market Analysis: Deep Space Economy
- Space-Based Datacenters: Feasibility Study
- Commercial Space Stations: Feasibility Study
- Defence Space and Missile Defence: Golden Dome and the SDA Architecture
- Launch After Starship: Prices, Capacity and European Sovereign Launch, 2026–2035
- Satellites to Phones: Direct-to-Device Connectivity, Spectrum and Economics, 2026–2035
- Space Supply Chain Bottlenecks: Components, Minerals and Capacity, 2026–2030
- Lunar, Cislunar and Settlement Economics: What the Moon Costs and Who Pays, 2026–2060
- Earth Observation and AI Analytics: What a Square Kilometre Is Worth and Who Captures It, 2026–2035
- In-Space Manufacturing and Microgravity Biotech: Products, Platforms and Economics, 2026–2035
- Space-Based Solar Power: Physics, Costs and the Path to Firm Power from Orbit, 2026–2050
€199 a month or €1,490 a year per sector, after a 7-day free trial. Cancel any time. Need several sectors? All sectors: €999 a month.
Check the live record Space Contracts & Tender Radar · Space Claim Check (free)
Ask about this chapter
Answers drawn from every Setcoin report and the live Atlas. Each statement links to the passage behind it.
Ask is included with every subscription
Cited answers across every report and the Atlas, with follow-up questions and a hand-off to the opportunity finder.
Research for professional investors. Not investment advice, and not an offer of any security or fund interest.